🔗 Share this article

Given that America proceeds with historic changes to its vaccine schedules, a particular individual has surfaced in a surprising turn: Dr. Tracy Beth Høeg, a US-based sports physician and public health researcher who rose to prominence by questioning Covid vaccinations in the global health crisis and has concentrated on alleged deaths following Covid vaccination in her recent time at the FDA.

Proposed Changes to Pediatric Immunization Schedule

Public health authorities had intended to reveal radical changes to the pediatric vaccination calendar in December, aligning the US with the Danish national calendar, sources say – a major change that would place the US at odds with many the global community with little proof for benefit. This reveal has been pushed back until the next year.

Rather than the director of the vaccine center, Dr. Høeg is listed to present at the meeting. She was newly appointed temporary leader of the FDA’s Center for Drug Evaluation and Research (CDER), the fifth appointee to lead the center this calendar year.

A Shift at the FDA

The acting appointment might represent a tighter collaboration between the pharmaceutical and biologics branches as Høeg and Dr. Prasad strengthen their influence at the regulatory agency – and it signals a renewed priority upon rolling back already-approved immunizations at the FDA.

The new acting director has frequently advocated for ending specific childhood shot schedules in the US so as to align more like the Danish model, a country with universal health coverage and a population approximately the size of Wisconsin’s.

In her initial comments, she has kept her attention on immunizations – usually the responsibility of Dr. Prasad, chief of the FDA’s Center for Biologics Evaluation and Research (CBER) – rather than pharmaceutical oversight.

Concerns Over Qualifications

The appointee has no obvious experience in medication creation, regulation or management, which has been standard for previous leaders of the Center for Biologics Evaluation and Research. She has served at the FDA as a senior adviser to the agency head and the vaccine center since March.

“She doesn’t seem to have the requisite experience” for running the drug-regulation department, remarked a neurologist and psychiatrist. “She lacks experience running a randomized controlled trial. She has no expertise in leading a large organization. She is not an expert in pharmaceutical oversight.”

Former heads of the center would “understand legal statutes and the research of drug development”, commented a former acting FDA commissioner. “Objectively, she doesn’t have the sort of resume that previous people who led CBER have had.”

CDER has an enormous range of responsibilities at the agency, Woodcock stated.

“Many people just focuses on the new drug program, but the generic program clears a multitude of generic medications. There is also a biosimilars division, non-prescription drug unit and other areas, and each of these need to be managed,” Woodcock said. “The area you don’t keep your eye on, that is the part that I always told people is going to come back to haunt you.”

There is also, a significant management element to the job, which oversees more than 5,000 employees. “It is a huge leadership role, if you do it right,” Woodcock said.

Official Statement and Contentious Initiatives

When asked about concerns about Dr. Høeg's qualifications and whether this assignment indicates more teamwork among agency officials on vaccines, a representative said that the “questions are based on inaccurate presumptions”.

“This background matches the duties of her job,” the representative said, noting the period Høeg spent advising the agency head on “medication safety and approval science, including predictive safety algorithms and vaccine surveillance”.

As the temporary head, Dr. Høeg assumes responsibility for the commissioner’s controversial fast-track approval initiative, a disputed one-day drug-approval program that allegedly troubled her predecessors. “How are these drugs being chosen for this expedited pathway? Who makes the choices?” Howard asked. “There’s a lot of confidentiality going on at the FDA right now.”

In general, he stated, “the Food and Drug Administration looks to be trending towards more relaxed rules of most medications, with the exception of vaccines.”

Established Past Work on Immunizations

With vaccines, Dr. Høeg has a clearer, if troubling, history, Howard observe. She released a research paper using unverified public submissions to assess the rate of myocarditis after Covid vaccination. She counseled the state of Florida chief medical officer Dr. Joseph Ladapo, who was said to have modified findings to suggest COVID-19 vaccines are more dangerous than they are.

Included in her “policy goals” for the new government encompassed revising rules for recently developed shots and ending “optional” immunizations, she stated post-election on a online show. At the agency, Høeg has reportedly suggested preventing teenage boys from receiving Covid vaccines.

“She is an thorough ideologue who begins with her beliefs and works backwards to accommodate the data in a very disingenuous, untruthful manner,” Howard stated.

Consolidating Power and a “Campaign of Retribution”

Dr. Høeg aligned with other skeptics, {like|